30 patients will receive monthly infusions of an antibody drug currently used to treat multiple sclerosis (MS), which the team hopes will target the root causes of schizophrenia in a far more fundamental way than current therapies.
7 Likes
This is great news.
1 Like
I hope it works but I won’t change treatments until it becomes obvious it does.
3 Likes
Since this is a 2 year trial, it’s supposed to wrap up at the end of this year.
1 Like
Very interesting, looking forward to reading about the results.
1 Like
Exciting. There hasn’t been a true change in frontline treatment in 50+ years. Setting up a dopamine blockade via drugs to ease positive symptoms still seems like the only thing psychiatrists know to do. May not get a treatment on the first drug trial but the article seems to indicate they are monitoring more than symptom relief.
But still, seems like greater recovery is more of a waiting game
2 Likes
This would be a miracle
1 Like
I wish I had grown up in the UK instead sometimes
1 Like
This topic was automatically closed 95 days after the last reply. New replies are no longer allowed.